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A molecular switch changes the signalling pathway used by the
FcgRI antibody receptor to mobilise calcium 
Alirio Melendez*, R. Andres Floto†, Angus J. Cameron*, David J. Gillooly*,
Margaret M. Harnett‡ and Janet M. Allen*
Background: Leukocytes express Fcγ receptors, which are specific for the
constant region of immunoglobulin G. Aggregation of these receptors activates
a repertoire of responses that can lead to targeted cell killing by antibody-
directed cellular cytotoxicity. The nature of the myeloid response to Fcγ receptor
aggregation is highly variable and depends on the maturation state of the cell,
but little is known about the signalling mechanisms underlying this variability. 
Results: We show here that differentiation of a monocytic cell line, U937, to a
more macrophage phenotype resulted in an absolute and fundamental switch in
the nature of the phospholipid signalling pathway recruited following Fcγ
receptor aggregation. In cytokine-primed monocytes, aggregation of the high-
affinity receptor FcγRI resulted in the activation of phospholipase D and
sphingosine kinase, which in turn led to the transient release of stored calcium;
these effects were mediated by the γ chain, an FcγRI accessory protein. In
contrast, in cells differentiated to a more macrophage type, aggregation of
FcγRI resulted in the FcγRIIa-mediated activation of phospholipase C, and the
resulting calcium response was prolonged as calcium entry was stimulated. 
Conclusions: The switch in FcγRI signalling pathways upon monocyte
differentiation is mediated by a switch in the accessory molecule recruited by
FcγRI, which lacks its own intrinsic signal transduction motif. As many immune
receptors have separate polypeptide chains for ligand binding and signal
transduction (allowing a similar switch in signalling pathways), the mechanism
described here is likely to be widely used.
Background
The Fcγ receptors of leukocytes are specific for the con-
stant region (Fc) of immunoglobulin G (IgG) molecules
and provide a pivotal link between the humoral and cellu-
lar arms of the immune system (see reviews [1–3]).
Antigen–antibody immune complexes aggregate Fcγ
receptors and trigger a number of different effector func-
tions in myeloid cells including endocytosis. Fcγ receptor
aggregation activates a repertoire of responses including
degranulation and release of proteases, activation of the
respiratory burst and release of cytokines. Activation of
these responses can ultimately lead to targeted cell killing
by antibody-directed cellular cytotoxicity [4,5], which is
critically important for clearing virus-infected cells and in
cancer surveillance [6]. One feature of monocytes and
macrophages harvested under different conditions and in
different environments is the heterogeneity of their
responses to immune complex challenge.
Three different classes of Fcγ receptors have been
defined on the basis of their structures and affinities for
IgG: FcγRI (CD64), FcγRII (CD32) and FcγRIII (CD16).
Human FcγRI, a high-affinity IgG receptor, is an integral
type I membrane glycoprotein [7] constitutively expressed
on monocyte and macrophage cell types. The cytoplasmic
tail of FcγRI contains no obvious signalling motif or
homology with other immune system receptors. Aggrega-
tion of FcγRI, however, results in signal transduction, seen
as protein tyrosine phosphorylation events [8–11] and
tyrosine kinase dependent calcium transients [12,13]. In
myeloid cells, FcγRI is associated non-covalently with the
γ chain protein [14,15], which contains an immunoreceptor
tyrosine activation motif (ITAM) necessary for activation
of soluble tyrosine kinases [16–18]. The γ chain, a 7 kDa
protein originally identified as a component of the high
affinity IgE receptor (FcεRI) in mast cells [19], is a
member of a family of signal transducing molecules that
includes the ζ chain of the T-cell receptor [20]. As a result
of the non-covalent association between FcγRI and the γ
chain, receptor aggregation results in clustering of the
associated γ chain ITAMs and thereby triggers tyrosine
kinase recruitment and activation [21–23]. 
Activation of Fcγ receptors leads to the tyrosine phospho-
rylation of phospholipase Cγ1 [8] and resulting cytosolic
calcium transients [10]. Little is known, however, about
Addresses: *Department of Medicine &
Therapeutics and Division of Biochemistry &
Molecular Biology, Davidson Building, University of
Glasgow, Glasgow G12 8QQ, Scotland, UK.
†Physiological Laboratory, University of Cambridge,
Cambridge CB2 3EG, UK. ‡Department of
Immunology, University of Glasgow, Glasgow G11
6NT, Scotland, UK.
Correspondence: Janet M. Allen
E-mail: janet.allen@bio.gla.ac.uk
Received: 14 November 1997
Revised: 18 December 1997
Accepted: 12 January 1998
Published: 28 January 1998
Current Biology 1998, 8:210–221
http://biomednet.com/elecref/0960982200800210
© Current Biology Ltd ISSN 0960-9822
the signal transduction mechanisms underlying FcγRI sig-
nalling or how these mechanisms are modified as blood
monocytes differentiate into tissue macrophages. Thus, to
study early events in the FcγRI signalling pathway, we
have used the human monocyte cell line U937 [24], which
constitutively expresses both FcγRI and the macrophage-
specific low-affinity IgG receptor FcγRIIa, which contains
an ITAM. U937 cells undergo controlled differentiation
into a more macrophage cell type upon treatment with
dibutyryl cAMP (dbcAMP) [25] and previous work has
shown that the nature of the calcium response markedly
changes as the cells become differentiated [12]. Thus,
monocytic U937 cells, when primed with interferon-γ
(IFN-γ), respond to Fcγ receptor aggregation with a single
‘spike’ of cytosolic calcium, whereas calcium oscillations
are generated in response to Fcγ receptor aggregation in
U937 cells differentiated to a more macrophage state by
dbcAMP [26]. We now show that differentiation causes a
fundamental and absolute developmental switch in the
particular phospholipase pathway recruited following Fcγ
receptor aggregation and that the calcium responses gen-
erated are consequent on this switch. 
Results
Section 1: mobilisation of calcium undergoes a
differentiation-dependent molecular switch
Differential generation of inositol phosphates following
aggregation of Fcγ receptors
To examine the mechanism underlying the differentia-
tion-dependent change in the calcium response of U937
cells, experiments were performed to define Fcγ receptor
coupling to lipid signalling pathways that generate candi-
date messengers for eliciting calcium release. Thus, as it is
well established that aggregation of Fcγ receptors leads to
the recruitment of tyrosine kinases and the subsequent
phosphorylation and presumed activation of phosphatidyl-
inositol 4,5 bisphosphate phospholipase C (PtdInsP2-
PLC) [8,10,11], with the resultant generation of the
calcium mobilising second messenger inositol-1,4,5-
trisphosphate (InsP3), our first approach was to investigate
coupling to this pathway. Aggregation of Fcγ receptors did
indeed have different effects on the activity of PtdInsP2-
PLC in U937 cells treated with IFN-γ and dbcAMP. A
small but significant transient rise in InsP3 levels was
observed following receptor aggregation in cells differenti-
ated with dbcAMP (Figure 1a). By contrast, no increase in
InsP3 levels could be detected following receptor aggrega-
tion using the same stimulus in cells treated with IFN-γ
(Figure 1a).
As the increase in measurable InsP3 was small and tran-
sient even in cells differentiated with dbcAMP, we also
measured the accumulation of total inositol phosphates in
the presence of lithium chloride (10 mM), which prevents
the breakdown of inositol phosphates [27,28], to ensure
that any transient generation was not missed by sampling
at specified time points. The results are shown in
Figure 1b. In dbcAMP-differentiated cells, aggregation of
Fcγ receptors initiated an increase in the levels of inositol
phosphates that was detectable at the first time point
tested (5 minutes) and steadily increased in a linear
fashion thereafter. Surprisingly, the levels of inositol phos-
phates were not increased above control values in cells
treated with IFN-γ even 20 minutes after receptor aggre-
gation (Figure 1b). Thus, the ability of activated Fcγ
receptors to generate inositol phosphates depends on the
differentiation state of U937 cells: InsP3 is generated in
dbcAMP-differentiated cells, but not in IFN-γ-treated
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Figure 1
Differential generation of inositol phosphates
following ligand activation of Fcγ receptor in
dbcAMP- and IFN-γ-treated cells. (a) InsP3
levels in dbcAMP- or IFN-γ-treated cells at set
times (30 sec to 20 min) after Fcγ receptor
aggregation. In dbcAMP-differentiated cells,
InsP3 concentrations were above control
(samples with no added cross-linking
antibody) values at all time points after Fcγ
receptor aggregation, although
concentrations appeared to oscillate. In IFN-γ-
treated cells, InsP3 concentrations were never
higher than control values at any time point.
The data shown are the mean ± the standard
deviation of triplicate measurements and are
representative of four different experiments.
(b) Total accumulated inositol phosphates
following Fcγ receptor aggregation in
dbcAMP- and IFN-γ-treated cells. Cells were
treated with 10 mM lithium chloride. Cells
were harvested at 5 min intervals after Fcγ
receptor aggregation and assayed for inositol
phosphate concentration. The data shown are
the mean ± the standard deviation of triplicate
measurements and are representative of five
separate experiments.
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cells. Indeed, the failure to detect any inositol phosphate
accumulation in IFN-γ-treated cells suggests that the
calcium spike previously documented in these cells is
induced in an InsP3-independent manner. 
Fcγ receptor is coupled to diacylglycerol production in both
differentiation states
Our first clue to the potential calcium-mobilising sig-
nalling pathway used by Fcγ receptor in IFN-γ-treated
cells was provided by experiments measuring mass dia-
cylglycerol (DAG) generation. Unexpectedly, in contrast
to the differences in levels of inositol phosphates,
broadly similar levels of DAG were produced by Fcγ
receptor aggregation in cells treated with IFN-γ or cells
differentiated using dbcAMP (Figure 2). As DAG can
also be generated by activation of either phosphatidyl-
choline phospholipase C (PtdCho-PLC) or phosphatidyl-
choline phospholipase D (PtdCho-PLD) [28] (from
phosphatidic acid (PtdOH) via phosphatidic acid phos-
phohydrolase), we next investigated whether either of
these alternative pathways was responsible. To do this,
DAG was measured in cells pretreated with butan-1-ol
(0.3%), which traps PtdOH, the immediate product of
PtdCho-PLD, in a non-hydrolysable form as phos-
phatidyl butanol (PtdBut) [28]. We controlled the speci-
ficity of this reaction using the stereoisoform butan-2-ol,
which cannot act as an acceptor for the phosphatidyl
moiety of PtdCho. In cells treated with IFN-γ, Fcγ-
receptor-mediated DAG production was completely
blocked by butan-1-ol whereas, in cells differentiated
with dbcAMP, DAG production was completely unaf-
fected (Figure 2). Butan-2-ol had no effect on DAG pro-
duction in either cell type (data not shown). These
results suggest that in dbcAMP-differentiated cells DAG
is, as expected from the observed levels of inositol phos-
phates, likely to be predominantly derived from
PtdInsP2-PLC signalling. In contrast, in IFN-γ-treated
cells DAG generation is entirely derived from coupling
of Fcγ receptors to a PLD pathway. 
Fcγ receptors are coupled to PLD in IFN-γ-treated cells but
not in dbcAMP-differentiated cells
To confirm that Fcγ receptor signalling in IFN-γ-treated
cells is indeed coupled to a PtdCho-PLD pathway, we
investigated coupling in [3H]palmitate-labelled U937 cells
using the transphosphatidylation assay [27]. These experi-
ments definitively showed that aggregation of Fcγ recep-
tors in IFN-γ-treated cells stimulated activation of
PtdCho-PLD, as demonstrated by the substantial genera-
tion of [3H]PtdBut in cells treated with butan-1-ol
(Figure 3), but not in cells treated with butan-2-ol for 30
minutes (data not shown). By contrast, no accumulation of
[3H]PtdBut was detected in cells differentiated with
dbcAMP (Figure 3). To ensure that differentiation with
dbcAMP had not downregulated PLD activity in these
cells, the level of activity following stimulation with the
phorbol ester PMA (phorbol 12,13 myristate acetate) was
compared in differentiated cells and those treated with
IFN-γ (Figure 3b). In both cell types, PMA (1 µM) stimu-
lated PLD essentially to an equivalent extent indicating
that although Fcγ receptors are not coupled to PtdCho-
PLD in dbcAMP-differentiated cells, one or more
PtdCho-PLD activities are expressed in these macro-
phage-like cells. These results, therefore, categorically
show differential coupling of the Fcγ receptors to major
phospholipid signalling pathways, PtdInsP2-PLC and
PtdCho-PLD, at different stages of monocyte differentia-
tion. Moreover, this switch in lipid signals is absolute. 
The FcγRI-mediated calcium response in IFN-γ-treated cells is
dependent on PLD and sphingosine kinase
As no InsP3 accumulation could be detected in IFN-γ-
treated cells following aggregation of FcγRI, alternative
routes for calcium release were investigated. As a sphin-
goid base has previously been implicated in mobilisation
of intracellular calcium stores [29–31], the differentiation-
dependent coupling of FcγRI to sphingosine kinase was
investigated in these cells. A prompt twofold increase in
sphingosine kinase activity was observed 30 seconds after
receptor aggregation in these cells whereas it was not acti-
vated in dbcAMP-differentiated cells. A specific link
between sphingosine kinase activation and PtdCho-PLD
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Figure 2
Relative DAG levels after aggregation of Fcγ receptors by ligand in
dbcAMP- and IFN-γ-treated cells. The effect of butanol (0.3%) on the
levels of DAG before (control) and after (X link) Fcγ receptor
aggregation was examined. The data shown are the mean ± the
standard deviation of triplicate measurements and are representative of
four separate experiments.
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was demonstrated by pretreating cells with 0.3% butan-1-ol,
which completely abolished the increase in sphingosine
kinase activity observed after specific aggregation of FcγRI
in IFN-γ-treated cells, whereas butan-2-ol had no effect on
sphingosine kinase activation (data not shown). This clearly
demonstrates that PtdCho-PLD activation is upstream of
sphingosine kinase, a finding that is consistent with the pre-
vious observation that PtdOH can stimulate sphingosine
kinase in vitro [32].
The role of components of the novel activation pathway
(PtdCho-PLD and sphingosine kinase) identified in
IFN-γ-primed cells in mediating the calcium transients
was determined. Consistent with a role for sphingosine
kinase, addition of the sphingosine kinase inhibitor D-L-
threo dihydro-sphingosine (DHS; 25µM) completely abol-
ished the FcγRI-mediated calcium response in
IFN-γ-treated but not dbcAMP-treated cells (data not
shown). Furthermore, preincubation of IFN-γ-primed
cells for 5 minutes with 0.3% butan-1-ol decreased the
peak cytosolic calcium mobilisation from 217 ± 30 nM to
99 ± 29 nM. 
Summary for section 1
Taking all this data together, we have shown that immune
complexes trigger different phospholipid signalling path-
ways dependent on the differentiation state of the cell. In
dbcAMP-differentiated cells, PtdInsP2-PLC is activated
and calcium mobilised through the conventional pathway
involving InsP3. In interferon-γ-primed cells, however, a
novel pathway has been identified that involves sequen-
tial activation of PtdCho-PLD and sphingosine kinase and
mobilisation of calcium through an InsP3-independent
route. Moreover, the calcium transients were inhibited by
both DHS and butanol, indicating that this pathway gen-
erates second messengers able to release calcium from
stores using a novel mechanism.
Section 2: mechanism of the switch
The phospholipid signalling pathway used depends on which
Fcγ receptor is aggregated 
The switch in the phospholipid signalling pathway
recruited by Fcγ receptor aggregation may result from the
influence of differentiation on any one of the components
of the pathway. To investigate whether the switch in
phospholipase activation is defined by the nature of the
predominant Fcγ receptor on the cell surface, monoclonal
antibodies specific for either FcγRI or FcγRIIa were used
to cross-link each receptor (see Materials and methods for
more details). We compared the results of cross-linking
the individual receptors with those obtained by immune
complex activation in both IFN-γ-treated and dbcAMP-
differentiated cells.
In dbcAMP-differentiated cells, specific aggregation of
either FcγRI or FcγRIIa gave similar results to those
observed using human IgG, namely a measurable rise in
the levels of inositol phosphates (Figure 4a,b) and DAG
(Figure 4c,d); the accumulation of the latter was unaf-
fected by pretreating the cells with 0.3% butan-1-ol. In
keeping with these results, no increase in PLD activity
was measured after cross-linking either receptor in these
differentiated cells (Figures 4e). To rule out the possibil-
ity that FcγRI signalling here simply reflected recruitment
of FcγRIIa by the Fc region of either anti-FcγRI mono-
clonal antibodies used (antibodies 22 and 32), which are
both of mouse IgG1 subclass and can be recognised at low
affinity by FcγRIIa [33], the level of inositol phosphates
was measured in dbcAMP-differentiated cells in the pres-
ence of either whole molecule intact monoclonal antibod-
ies 22 and 23 or a F(ab′)2 preparation of the same
antibodies. Polyclonal mouse IgG was used an an addi-
tional control. The intact anti-FcγRI antibodies and their
F(ab′)2 fragments gave an identical accumulation of inosi-
tol phosphates whereas mouse IgG1 did not stimulate the
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Figure 3
Measurement of PLD activity in dbcAMP- and
IFN-γ-treated cells using the
transphosphatidylation assay. (a) PLD activity,
measured as the accumulation of [3H]PtdBut
in cells before (control) and 30 min after
(X link) aggregation of Fcγ receptors. (b) PLD
activity in dbcAMP- or IFN-γ-treated cells
following activation by phorbol ester (PMA).
The data shown are the mean ± the standard
deviation of triplicate measurements and are
representative of six separate experiments.
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generation of inositol phosphates (Figure 4f). Thus, in
dbcAMP-differentiated cells, both FcγRI and FcγRIIa
appear to be coupled to PtdInsP2-PLC and neither recep-
tor is coupled to PtdCho-PLD. These results agree with
those seen when Fcγ receptors are aggregated by immune
complexes in dbcAMP-treated cells. 
In contrast, in IFN-γ-treated cells, completely different
patterns of signalling were obtained by cross-linking spe-
cific Fcγ receptors. Only specific aggregation of FcγRI
gave similar results to those obtained using immune com-
plexes, namely no detectable accumulation of inositol
phosphates (Figure 5a,b), a rise in DAG levels which was
abolished by pretreating cells with 0.3% butan-1-ol
(Figure 5c,d) and an increase in PLD activity (Figure 5e).
By contrast, specific aggregation of FcγRIIa in IFN-γ-
treated cells using monoclonal antibodies gave an identical
pattern of responses to that observed for dbcAMP-differ-
entiated cells, namely an increase in inositol phosphates
(Figure 5a,b) and butan-1-ol-insensitive DAG generation
(Figure 5c,d) with no increase in PLD activity (Figure 5e).
Thus, in IFN-γ-treated cells, FcγRI is coupled to PtdCho-
PLD and FcγRIIa to PtdInsP2-PLC. Taken together,
these data indicate that FcγRIIa always signals through the
activation of PtdInsP2-PLC regardless of the differentia-
tion state of the cell. In contrast, FcγRI appears to switch
its coupling to different phospholipid signalling pathways
in a differentiation-dependent manner. In dbcAMP-differ-
entiated cells, FcγRI is coupled to PtdInsP2-PLC and
thereby adopts a signalling pattern that is identical to that
observed for FcγRIIa. In IFN-γ-treated cells, FcγRI is
independently coupled to PtdCho-PLD and unlike
FcγRIIa is not coupled to PtdInsP2-PLC. This switch in
coupling to different phospholipid signalling pathways by
214 Current Biology, Vol 8 No 4
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Response of dbcAMP-differentiated cells to specific cross-linking of
FcγRI or FcγRIIa using monoclonal antibodies. (a,b) Accumulation of
inositol phosphates at specified times after specific receptor cross-
linking. (c,d) DAG generation 30 min after specific receptor cross-
linking for the indicated times and the effect of butanol on DAG
production. (e) PLD activity after specific receptor cross-linking. The
data shown are the mean ± the standard deviation of triplicate
measurements and are representative of five separate experiments.
(f) Comparison of the ability of intact anti-FcγRI monoclonal antibodies
and F(ab′)2 preparations to induce inositol phosphate generation in
dbcAMP-differentiated cells. In the presence of 10 mM LiCl, cells were
loaded with either no primary antibody (control), or equivalent
concentrations of polyclonal monomeric mouse IgG1 (mIgG1), the
F(ab′)2 preparations of the FcγRI-specific monoclonal antibodies 22
and 32 (α-FcγRI F(ab′)2), intact antibodies 22 and 32 (α-FcγRI) or
polyclonal monomeric human IgG1 (hIgG1). Following addition of the
appropriate secondary antibodies and warming of cells to 37°C for
20 min, total inositol phosphates were measured. The results are the
mean ± the standard deviation of triplicate measurements. 
FcγRI is absolute and is identical to that observed for
ligand (human IgG) activation (Figures 1–3). 
The FcγRI-dependent pathway in IFN-γ-treated cells is
coupled to sphingosine kinase activation
As our studies had linked the activation of PtdCho-PLD
with sphingosine kinase, the coupling of specific Fcγ
receptors to sphingosine kinase and the effect of differen-
tiation on its activation were examined using the mono-
clonal antibodies to aggregate each receptor specifically.
Consistent with the identified switch in phospholipid sig-
nalling pathways, sphingosine kinase activity was stimu-
lated only following the specific aggregation of FcγRI in
IFN-γ-primed cells (Figure 6). The sphingosine kinase
activity did not rise above control values following aggre-
gation of FcγRIIa in IFN-γ-treated cells or following
aggregation of either FcγRI or FcγRIIa in dbcAMP-differ-
entiated cells (Figure 6). Thus, the receptor specificity of
sphingosine kinase activation exactly parallels that
observed for activation of PtdCho-PLD (Figures 4e,5e).
These data therefore indicate that, in IFN-γ-treated cells,
FcγRI is coupled to a pathway dependent on PtdCho-
PLD and sphingosine kinase whereas, in dbcAMP-treated
cells, FcγRI is coupled to PtdInsP2-PLC and production
of InsP3. In contrast, FcγRIIa is coupled to the pathway
dependent on PtdInsP2-PLC and InsP3 in both cell types.
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Figure 5
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FcγRlla cross-linking antibodies
FcγRl cross-linking antibodies
Control (no antibodies)
Response of IFN-γ-treated cells to specific cross-linking of FcγRI or
FcγRIIa using monoclonal antibodies. (a,b) Accumulation of inositol
phosphates at specified times after specific receptor cross-linking.
(c,d) DAG generation 30 min after specific receptor cross-linking for
the indicated times and the effect of butanol on DAG production.
(e) PLD activity after specific receptor cross-linking. The data shown
are the mean ± the standard deviation of triplicate measurements and
are representative of four separate experiments.
Figure 6
Sphingosine kinase activity in cells treated with IFN-γ or dbcAMP
followed by specific receptor (FcγRI or FcγRIIa) cross-linking using
monoclonal antibodies. Controls are IFN-γ-treated cells with no cross-
linking antibody added. The data shown are the mean ± the standard
deviation of triplicate measurements and are representative of three
separate experiments.
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The switch in phospholipid signalling pathways is matched by
a change in the nature of the calcium response
Differentiation of U937 cells with dbcAMP changes the
nature of calcium transient responses to Fcγ receptor
aggregation stimulated by immune complexes. Thus, in
dbcAMP-differentiated cells, about 50% of cells respond
in the form of calcium oscillations [26] whereas in undif-
ferentiated or IFN-γ-treated cells, the calcium response is
in the form of a single spike. To determine whether the
differential calcium responses observed following matura-
tion reflect the change in the phospholipid signalling
pathway recruited, we compared the nature of the calcium
response resulting from aggregation of either FcγRI or
FcγRIIa using monoclonal antibodies with the response
triggered by cross-linking the ligand, human IgG. 
In dbcAMP-differentiated cells, about 50% of cells
responded with calcium oscillations, regardless of the
nature of the Fcγ receptor aggregated (Figure 7a–c,g). In
cells treated with IFN−γ, the nature of the aggregated
receptor switched the nature of the calcium response
(Figure 7d–g); thus, specific aggregation of FcγRI
resulted in a single spike of calcium (Figure 7e), identical
to that observed in response to human IgG (Figure 7d),
and specific cross-linking of FcγRIIa gave calcium oscilla-
tions in 50% of the cells, identical to those observed in
dbcAMP-differentiated cells (Figure 7a–c,f,g). Thus, the
failure to observe calcium oscillations following ligand
activation in IFN-γ-treated cells is not a feature of their
lack of the appropriate cellular machinery as, given the
relevant trigger (FcγRIIa cross-linking), these cells are
able to establish calcium oscillations. 
These data indicate that aggregation of FcγRIIa initiates
calcium oscillations in U937 cells regardless of their differ-
entiation status (Figure 7c,f,g). The finding that specific
aggregation of FcγRI in the two differentiation states gives
different calcium responses completely matches the
observed differentiation-dependent switch in phospho-
lipid signalling pathways. Thus, the differentiation-
dependent switch in the activated phospholipid pathway
dictates the nature of the calcium response.
Changes in FcγRIIa and γ chain expression upon IFN-γ and
dbcAMP treatment are identical
Activation of both phospholipid pathways depended on
the initial activation of tyrosine kinases: pretreatment of
cells with the tyrosine kinase inhibitor genistein
(0.37 mM) completely abolished the rise in PtdCho-PLD
and sphingosine kinase activities following FcγRI aggre-
gation in IFN-γ-treated cells (data not shown). To acti-
vate tyrosine kinases, FcγRI must recruit an accessory
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Calcium responses in IFN-γ- and dbcAMP-treated cells following Fcγ
receptor aggregation by ligand or cross-linking of specific Fcγ
receptors using monoclonal antibodies. (a–f) Changes in Fluo3
fluorescence as an indication of cytosolic calcium — representative
traces from three cells (from different experiments) in either (a–c)
dbcAMP-differentiated cells or (d–f) IFN-γ-treated cells. (a,d) Fcγ
receptor aggregation triggered by cross-linking monomeric human
IgG; (b,e) cross-linking of FcγRI using specific monoclonal antibodies
22 and 32; (c,f) cross-linking of FcγRIIa using specific monoclonal
antibody 2e1 on cells preloaded with human IgG4 to block the binding
site of FcγRI (detailed in Materials and methods). (g) Statistical
analysis of the proportion of cells responding with calcium oscillations
or a single spike of calcium influx under the conditions shown in (a–f).
Each condition — cross-linking using IgG (norm), anti-FcγRI antibodies
(FcγRI) or anti-FcγRIIa antibodies (FcγRIIa) — was examined in four
separate experiments. The mean value and standard error is given for
each condition; at least 200 individual cells were analysed.
molecule as it contains no ITAM in its cytoplasmic tail.
We therefore investigated whether IFN-γ and dbcAMP
differentially induced expression of the γ chain and
FcγRIIa, the two ITAM-bearing molecules able to inter-
act with FcγRI. 
Consistent with previous reports [7], IFN-γ treatment
resulted in a transient 15-fold increase of FcγRI mRNA
levels (Figure 8a). This transient rise in mRNA markedly
precedes the increase in surface expression of FcγRI [7].
IFN-γ also increases both surface FcγRIIa [12] and the γ
chain protein [14] in U937 cells. Consistent with these
previous observations of protein expression, IFN-γ
resulted in a transient increase of mRNA levels of both
FcγRIIa and the γ chain (Figure 8a). However, both these
rises were much smaller (twofold over basal levels) than
that observed for FcγRI mRNA, although the time course
of the response for all three transcripts was identical.
Treatment of cells with dbcAMP resulted in a steady
decrease in the amount of FcγRI mRNA such that after
48 hours levels had fallen to 50% of the starting level
(Figure 8b); however, as the protein on the cell surface
appears to be stable, surface FcγRI remains readily
detectable on these cells [12]. In contrast, levels of
FcγRIIa mRNA rose steadily over time. These results of
differential control of FcγRI and FcγRIIa expression are
consistent with the known relative pattern of surface
expression of the two receptors [12]. Surprisingly, γ chain
mRNA levels also rose during treatment of the cells with
dbcAMP in an identical manner to that observed for
FcγRIIa (Figure 8b). Thus, the mRNAs encoding both
ITAM-containing molecules behave in an identical
fashion following cytokine treatment and differentiation.
Regulation of the molecular switch in FcγRI signal trans-
duction must therefore be more complex than a mere
change in the relative stoichiometry of FcγRI to either of
its accessory molecules.
Mechanism of the molecular switch in FcγRI-mediated
signalling following differentiation
The role of the two accessory molecules (FcγRIIa and the
γ chain) in signal transduction by FcγRI was next investi-
gated by blocking the induction of their expression using
antisense oligonucleotides. In IFN-γ-treated cells, loading
cells with antisense γ chain completely abolished the
increase in PtdCho-PLD activity observed following spe-
cific aggregation of FcγRI with monoclonal antibodies
(Figure 9a). Loading cells with an equivalent antisense
oligonucleotide to FcγRIIa had no influence at all on
FcγRI-stimulated activation of PtdCho-PLD (Figure 9a).
In IFN-γ-treated cells, we have shown that specific aggre-
gation of FcγRIIa activates PtdInsP2-PLC with generation
of inositol phosphates (Figure 5a). Therefore, to check the
specificity of these antisense oligonucleotides, their ability
to interfere with FcγRIIa-mediated activation of PtdInsP2-
PLC was investigated. The normal increase in inositol
phosphates observed after specific aggregation of FcγRIIa
was blocked in cells loaded with the oligonucleotide anti-
sense to FcγRIIa (Figure 9b). The oligonucleotide anti-
sense to the γ chain had no influence on the ability of
FcγRIIa to activate PtdInsP2-PLC (Figure 9b). These
data, therefore, definitively demonstrate that FcγRI is
coupled to PtdCho-PLD activation through the γ chain in
IFN-γ-treated cells and that FcγRIIa plays no role in
signal transduction for the high-affinity receptor in these
cytokine-primed cells. 
In cells differentiated to macrophage type using dbcAMP,
FcγRI switches the nature of the activated intracellular
signalling pathway by switching the accessory molecule
used for signal transduction. Thus, loading differentiated
cells with antisense FcγRIIa completely abolished the
accumulation of inositol phosphates observed after aggre-
gation of either FcγRIIa or FcγRI (Figure 9c). In contrast
to the results in IFN-γ-treated cells, loading these differ-
entiated cells with antisense γ chain had no effect on
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Figure 8
Levels of mRNA for FcγRI, FcγRIIa and the γ
chain. (a) U937 cells were treated with IFN-γ
and cells harvested at 0, 1, 3, 6, 12 and 24 h.
Equal amounts of total RNA from each time
point were electrophoresed through a
formaldehyde 1% agarose gel. After transfer
on to nylon membranes, specific transcripts
for FcγRI, FcγRIIa and γ chain were visualised
using the relevant 32P-labelled probes.
(b) U937 cells were treated with dbcAMP
and cells harvested at 0, 1, 3, 6, 12 and 48 h.
Total RNA extracted from these cells was
handled as in (a). The positions of 28S and
18S RNAs are indicated.
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FcγRI-mediated signalling (Figure 9c). These data there-
fore, definitively demonstrate that following differentia-
tion FcγRI recruits FcγRIIa for signal transduction. 
The antisense oligonucleotides act as reciprocal internal
controls for each other as neither antisense oligonu-
cleotide influenced the receptor activation of the alter-
native pathway (Figure 9a–c). Moreover, surface
expression of total immunoreactive FcγRII was reduced
by some 30% in cells treated with the oligonucleotide
antisense to FcγRIIa (data not shown). As monoclonal
antibodies to FcγRII are unable to distinguish between
the six potential isoforms of FcγRII, this observation
probably represents a considerable underestimate of the
specific effect of the antisense oligonucleotide on the
expression of FcγRIIa, the only ITAM-bearing form of
FcγRII. Finally, for both pathways, a standard ‘jumbled’
antisense control oligonucleotide was also assessed for
nonspecific effects. Loading cells with this oligonu-
cleotide did not influence the activation of either
pathway (Figure 9d,e). Taken together, these data
clearly demonstrate that the differentiation-dependent
switch in signalling pathways recruited by aggregated
FcγRI results from a change in its recruitment of acces-
sory molecules.
Summary for section 2
The notable findings from this study are, firstly, that the
two Fcγ receptors (FcγRI and FcγRIIa) initiate fundamen-
tally different phospholipid signalling pathways in IFN-γ-
treated cells. Both pathways are present, intact and
functional in IFN-γ-treated cells but the two Fcγ receptors
are differentially and exclusively coupled. The second
finding is that the phospholipid pathway activated by spe-
cific cross-linking of FcγRI in monocytic and macrophage-
like cells exactly mimics the differentiation-dependent
switch in intracellular signalling observed for immune
complex activation and results from a switch in the ability
of this receptor to recruit different ITAM-bearing acces-
sory molecules following differentiation.
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FcγRlla cross-linking antibodies
FcγRl cross-linking antibodies
Control (no antibodies)
Loading of cells with antisense oligonucleotides demonstrates that
FcγRI is coupled to PtdCho-PLD through the recruitment of the γ chain
in IFN-γ-treated cells but is coupled to PtdInsP2-PLC through FcγRIIa
in dbcAMP-differentiated cells. (a,b) U937 cells were loaded with
either antisense γ chain or antisense FcγRIIa prior to treatment with
IFN-γ overnight. Specific aggregation of FcγRI or FcγRIIa was achieved
using monoclonal antibodies (see Materials and methods for more
details). PtdCho-PLD activity (a) and the accumulation of inositol
phosphates 20 min after receptor aggregation (b) were measured. The
data shown are the mean ± the standard deviation of triplicate
measurements. (c) U937 cells were loaded with either antisense γ
chain or antisense FcγRIIa prior to treatment for 48 hours with
dbcAMP (1 mM). The total accumulation of inositol phosphates was
measured in cells 20 min after the specific aggregation of FcγRI or
FcγRIIa using monoclonal antibodies. The data shown are the mean ±
the standard deviation of triplicate measurements. (d) IFN-γ-primed
U937 cells were loaded with a jumbled antisense control
oligonucleotide and the effect on FcγRI coupling to PtdCho-PLD was
assessed. (e) DbcAMP-differentiated U937 cells were loaded with the
jumbled antisense control oligonucleotide and the effect on FcγRIIa
coupling to PtdInsP2-PLC was assessed. 
Discussion
We have shown that there is a fundamental and absolute
switch in the nature of the intracellular signalling pathway
activated by immune complexes when a monocytic cell
line differentiates to a more macrophage-like cell. Thus,
in cells primed with IFN-γ, the release of intracellular
calcium from stores is InsP3 independent and is mediated
by the sequential activation of PtdCho-PLD and sphingo-
sine kinase. This newly identified signalling pathway pre-
sumably involves a sphingoid base acting on the recently
cloned SCaMPER receptor [34] in the endoplasmic reticu-
lum to effect the release of calcium from stores [29]. In
dbcAMP-differentiated cells, the same immune complex
challenge resulted in the activation of only PtdInsP2-PLC;
activation of the pathway involving PtdCho-PLD and
sphingosine kinase could not be detected. 
The ability of FcγRI to switch signalling pathways reflects
the fact that, unlike FcγRIIa, the cytoplasmic tail of FcγRI
contains no known signalling or ITAM motif but must
recruit one of two accessory molecules. Therefore, unlike
FcγRIIa, which through its intrinsic ITAM [33] demon-
strates obligate coupling to PtdInsP2-PLC, FcγRI is able
to switch recruitment between the γ chain and FcγRIIa in
a differentiation-dependent fashion and thereby couple to
different intracellular signalling pathways. In dbcAMP-
differentiated cells, FcγRI recruits FcγRIIa whereas, in
cytokine primed cells, FcγRI uses the γ chain. The control
of this switch does not rely on regulation of levels of the γ
chain but rather appears to depend on the relative levels
of FcγRI and FcγRIIa. The activation of different sig-
nalling pathways probably accounts for the different
responses of myeloid cells to challenge with immune com-
plexes. As many immune receptors have separate
polypeptide chains for ligand binding and signal transduc-
tion (allowing a similar switch in signalling pathways) the
mechanism defined here is likely to be widely used. 
Implications for myeloid function of the differential
signalling by Fcg receptors
The finding that differentiation to a more macrophage cell
type causes U937 cells to switch the signalling pathways
activated by Fcγ receptors such that prolonged calcium
signals are generated agrees with our previous finding that
dbcAMP upregulates capacitative calcium entry [35,36],
which is required for refilling of the calcium stores. It is
tempting to speculate that the differentiation process
primes cells to produce a prolonged response to immune
complex activation by switching the nature of the second
messenger to InsP3 and inducing capacitative calcium
entry to allow store filling, thereby maintaining the calcium
signal. Another likely immediate consequence of this
switch in phospholipase activation and calcium signalling is
the differential activation of protein kinase C isoforms,
which are involved in a number of myeloid functions such
as phagocytosis and endocytosis [37]. Such differential
protein kinase C signalling may explain the finding that
FcγRI-triggered phagocytosis is calcium independent
whereas FcγRII-mediated phagocytosis can be inhibited
by buffering cytoplasmic calcium [38]. Thus, this funda-
mental and absolute molecular switch in the activation of
phospholipid signalling pathways following differentiation
of cells to a macrophage cell phenotype provides a method
of precisely controlling the nature of the cellular response
to immune complexes.
Materials and methods
Materials and cell culture
U937 cells were cultured in RPMI1640 (Gibco) supplemented with
foetal calf serum (10%), glutamine (2 mM, penicillin (10 U/ml) and strep-
tomycin (10 µg/ml) at 37°C, 6.8% carbon dioxide in a water saturated
atmosphere. The cells were treated with IFN-γ (Bender Wein Ltd;
200 ng/ml) for 24 h or dbcAMP (1 mM) for 48 h. Antisense oligonu-
cleotides were purchased from Oswell DNA Services; 24-mers were
synthesised, capped at either end by the phosphothiorate linkages (first
two and last two linkages), and corresponded to the reverse comple-
ment of the first 8 amino acids for either the γ chain or FcγRIIa. The
sequences of the oligonucleotides were 5′-GAGCAAGACCACTGC-
TGGAATCAT-3′ for the γ chain, 5′-TCTGGGACATACATTCTGAGA-
CAT-3′ for FcγRIIa, and the jumbled control 5′-CTGGTGGA-
AGAAGAGGACGTCCAT-3′. Cells were incubated in 10 µM oligonu-
cleotide for 1 hour prior to, and then for the duration of, culture with
either IFN-γ or dbcAMP.
Receptor aggregation for the biochemical assays
Cells were harvested by centrifugation (200 g). For experiments using
ligand to aggregate the receptors, cells were incubated for 30 min on
ice with 1 µM human monomeric, polyclonal IgG (Serotec) to occupy
the surface FcγRI. Excess unbound ligand was removed by dilution and
centrifugation of the cells. Cells were resuspended and ligand-occu-
pied receptors were then aggregated by addition of 1:100 dilution of
F(ab) goat anti-human IgG (Sigma) on ice (Figure 10). Cells were then
warmed to 37°C for the times specified in the assays. To aggregate
specific Fcγ receptors, cells were incubated with specific monoclonal
antibodies for 30 min on ice (Figure 10). To aggregate FcγRI, cells
were incubated with 1 µg of the monoclonal antibodies 22 and 32
which recognise separate epitopes on FcγRI away from the binding
pocket. To aggregate FcγRIIa specifically, cells were incubated with
the monoclonal antibody 2e1 (Serotec) in the presence of 3 µM human
IgG4 (Serotec) to occupy the ligand-binding pocket of FcγRI. After
removal of excess antibody by dilution and centrifugation, the receptors
were cross-linked by the addition of F(ab) goat anti-mouse IgG F(ab)
(1:50 dilution; Sigma). Cells were then warmed to 37°C for the times
specified in the assays.
Measurement of inositol phosphates, DAG, PLD activity and
sphingosine kinase activity
Inositol phosphates were assayed essentially as described in Harnett
and Harnett [39], mass DAG was measured as described in Briscoe et
al. [27], PLD activity was measured by the transphosphatidylation assay
[27,28] and sphingosine kinase was assayed as described in Olivera et
al. [40]. More details of these methods are available as Supplementary
material (published with this paper on the internet). 
Single cell measurement of changes in cytosolic calcium 
U937 cells treated with dbcAMP (1 mM) or IFN-γ (200 ng/ml) were
harvested and cells resuspended in HEPES-buffered saline (HBS) sup-
plemented with 1 mM CaCl2. Cells were incubated simultaneously with
primary antibody (either human human IgG (1 µM) or the FcγRI-specific
monoclonal antibody 32 or FcγRIIa-specific monoclonal antibody 2e1
plus 1 µM human IgG4) and 5 µM Fluo3-AM (Molecular Probes) mixed
with an equal volume of 25% w/v Pluronic F127 at room temperature
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for 30 min. After centrifugation, cells were resuspended in HBS con-
taining 1 mM Ca2+ at room temperature and aliquots were settled on
poly-L-lysine coated coverslips and placed in a perfusion chamber
heated to 37°C. The perfusion bath was thoroughly perfused with HBS
containing 2 mM Ca2+ to remove excess antibody and ensure com-
plete solution change. For cells loaded with human IgG, receptors
were then aggregated by addition of F(ab) fraction of goat anti-human
IgG F(ab) antibody (1:50 dilution). For cells loaded with the FcγR-spe-
cific monoclonal antibodies, receptors were cross-linked with a F(ab)
preparation of a goat antibody specific for mouse IgG F(ab). Scanning
confocal imaging was achieved using a Zeiss inverted confocal micro-
scope. Excitation light (488 nm) was provided by an argon laser and
emitted light was detected at wavelengths above 515 nm. Laser atten-
uation, pinhole size and photomultiplier brightness/contrast settings
were maintained constant for all experiments. Frames were acquired
every 3 sec (512 × 512 pixels) and pixels assigned intensity values
(0–255). Transmitted visible light images were routinely taken before
and after every experiment to exclude artefactual changes in fluores-
cence caused by movement of cells in the focal plane. Results were
adjusted for dye photobleach assessed in unstimulated cells. Data
analysis were carried out using Metamorph and Sigmaplot (Jandel Sci-
entific Corp) software. Oscillations were defined as responses with
two or more peaks separated by more than one data point.
Measurement of calcium concentrations in cell populations 
To measure the release of calcium from intracellular stores, experi-
ments were performed on cell populations in nominally Ca2+ free HBS
(at 37°C) using a Cairn Research Spectrophotometer and cells loaded
with fura-2 (Molecular Probes) as described previously [12,41].
Northern blot analysis
Cells were treated with IFN-γ or dbcAMP and harvested at set times.
Messenger RNA for FcγRI, FcγRIIa and γ chain were probed by north-
ern blot analysis using cDNAs for each as described previously
[7,19,33]. 
Supplementary material available
Details of some of the methods used are published with this paper on
the internet.
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recognise FcγRI through their F(ab) region. FcγRI is then aggregated
by addition of F(ab) goat anti-mouse IgG F(ab) (GαM). (c) Specific
cross-linking of FcγRIIa. The monoclonal antibody 2e1 specifically
recognises FcγRIIa through the F(ab) region. However, this mAb can
bind to FcγRI at high affinity through its Fc region as it is a murine
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Materials and methods
Measurement of inositol phosphates 
Inositol phosphates were assayed essentially as described in Harnett
and Harnett [39]. Briefly, U937 cells were labelled with myo-[3H]inosi-
tol (1 µCi/106 cells) for 16 h at 37°C. To measure total accumulated
inositol phosphates, cells (at 1–3 × 107 cells/ml) were incubated for
10 min in the presence of 10 mM LiCl in RPMI 1640/10 mM
HEPES/0.1% BSA (RHB) medium, pH 7.4 prior to receptor cross-
linking and 10 mM LiCl was added to all solutions throughout [27,28].
Following cross-linking of the receptors, the cells were extracted by a
Bligh–Dyer phase separation and levels of [3H]InsP3 or total [3H]inosi-
tol phosphates (reaction mixture containing 10 mM LiCl) were deter-
mined by liquid scintillation counting of fractions eluted following
Dowex (formate form) ion-exchange chromatography of aliquots of the
aqueous phase.
Measurement of DAG generation 
Mass DAG was measured as described in Briscoe et al. [27]. The
lower organic phase of Bligh–Dyer extractions were dried in vacuo and
the lipids solubilised in a Triton X-100/phosphatidylserine mixture. E.
coli diacylglycerol kinase (Calbiochem) was added to a final concentra-
tion of 5 mUnits/ml and the reaction started by addition of 10 µl of
5 mM ATP containing 1 µCi of γ-[32P]ATP made up in 100 mM imida-
zole pH 6.6. After 30 min, the reaction was stopped by addition of 1 ml
of chloroform:methanol:HCl (150:300:2) and phases separated by
addition of 300 µl of chloroform and 400 µl of H2O. Samples of the
organic phase were then dried in vacuo, solubilised in 40 µl of chloro-
form:methanol (19:1) and resolved on silica TLC plates (Merck, 5714,
5 × 20 cm 60F254) developed in chloroform:methanol:acetic acid
(38:9:4.5). The PtdOH band (relative to standards) was scraped and
the associated radioactivity determined by liquid scintillation counting. 
Measurement of phospholipase D activity
PLD activity was measured by the transphosphatidylation assay
[27,28]. Briefly, U937 cells, were labelled (106 cells/ml) with
[3H]palmitic acid (5 µCi/ml) in RPMI 1640 medium containing 5% (v/v)
foetal calf serum for 16 h. Following labelling, the cells were washed in
ice-cold RHB medium, resuspended at 2 × 106 cells/ml and incubated
at 37°C for 15 min in RHB medium containing butan-1-ol (0.3% final).
Specific Fc receptors were cross-linked as described above and, after
the times indicated, cells were extracted by Bligh–Dyer phase separa-
tion. Samples of the lower organic phase were resolved on prerun, heat
activated TLC plates (20 × 20 cm, Silica gel 150A grooved plates,
Whatman) developed in the organic phase of the solvent, ethyl
acetate:2,2,4-trimethylpentane:acetic acid:water (11:5:2:10). The
[3H]PtdBut-containing silica indicated by the phosphatidylbutanol stan-
dard was then scraped into scintillation fluid and counted. 
Measurement of sphingosine kinase activity
Sphingosine kinase was assayed as described in Olivera et al. [40].
Reactions were terminated at the times specified in Figure 6 by addi-
tion of ice-cold phosphate buffered saline. After centrifugation, the cells
were resuspended in ice-cold 0.1M phosphate buffer (pH 7.4) contain-
ing 20% glycerol, 1 mM mercaptoethanol, 1 mM EDTA, phosphatase
inhibitors (20 mM ZnCl2, 1 mM sodium orthovanadate and 15 mM
sodium fluoride), protease inhibitors (10 µg/ml leupeptin, 10 µg/ml
aprotinin and 1 mM PMSF) and 0.5 mM 4-deoxypyridoxine. Cells were
disrupted by freeze thawing and centrifuged at 105,000 g for 90 min at
4°C. Supernatants were assayed for sphingosine kinase activity using
sphingosine (Sigma) and γ-[32P]ATP (2 µCi, 5 mM). as specified in
Olivera et al. [40]. After incubation, products were separated by TLC
on silica gel G60 using chloroform:methanol:acetic acid:water
(90:90:15:6) and visualised by autoradiography. The radioactive spots
corresponding to sphingosine phosphate were scraped and counted in
a scintillation counter.
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